Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Courtney E Meilleur"'
Autor:
Courtney E Meilleur, Arash Memarnejadian, Adil N Shivji, Jenna M Benoit, Stephen W Tuffs, Tina S Mele, Bhagirath Singh, Jimmy D Dikeakos, David J Topham, Hong-Hua Mu, Jack R Bennink, John K McCormick, S M Mansour Haeryfar
Publikováno v:
PLoS Pathogens, Vol 16, Iss 5, p e1008393 (2020)
Infection with (SAg)-producing bacteria may precede or follow infection with or vaccination against influenza A viruses (IAVs). However, how SAgs alter the breadth of IAV-specific CD8+ T cell (TCD8) responses is unknown. Moreover, whether recall resp
Externí odkaz:
https://doaj.org/article/f610b5aac89a4fe5a0c71a022d8a9c93
Autor:
Mateusz Rytelewski, Courtney E Meilleur, Maryam Atef Yekta, Peter A Szabo, Nitan Garg, Todd D Schell, Anthony M Jevnikar, Shayan Sharif, Bhagirath Singh, S M Mansour Haeryfar
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e90439 (2014)
Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-degrading enzyme known to suppress antitumor CD8(+) T cells (TCD8). The role of IDO in regulation of antiviral TCD8 responses is far less clear. In addition, whether IDO controls both immunodominant a
Externí odkaz:
https://doaj.org/article/e253d44b65f54714901f4d39f3e3a7d1
Autor:
Todd D. Schell, Christopher R. Shaler, S. M. Mansour Haeryfar, Arash Memarnejadian, Courtney E. Meilleur, Jack R. Bennink, Khashayarsha Khazaie
Publikováno v:
The Journal of Immunology. 199:3348-3359
The interactions between programmed death-1 (PD-1) and its ligands hamper tumor-specific CD8+ T cell (TCD8) responses, and PD-1-based “checkpoint inhibitors” have shown promise in certain cancers, thus revitalizing interest in immunotherapy. PD-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f88a224c91d1fbc16abc6dc7db4d195
https://doi.org/10.4049/jimmunol.1700643
https://doi.org/10.4049/jimmunol.1700643
Publikováno v:
Journal of visualized experiments : JoVE. (147)
Carboxyfluorescein succinimidyl ester (CFSE)-based in vivo cytotoxicity assays enable sensitive and accurate quantitation of CD8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9375f78b88a558c0e618b2714ddbd75c
https://pubmed.ncbi.nlm.nih.gov/31107454
https://pubmed.ncbi.nlm.nih.gov/31107454
Autor:
Arash Memarnejadian, Jimmy D. Dikeakos, John K. McCormick, Courtney E. Meilleur, S. M. Mansour Haeryfar, Jack R. Bennink, Adil N. Shivji, Stephen W. Tuffs, David J. Topham, Hong-Hua Mu, Jenna M. Benoit, Tina Mele, Bhagirath Singh
Publikováno v:
PLoS Pathogens, Vol 16, Iss 5, p e1008393 (2020)
PLoS Pathogens
PLoS Pathogens
Infection with (SAg)-producing bacteria may precede or follow infection with or vaccination against influenza A viruses (IAVs). However, how SAgs alter the breadth of IAV-specific CD8+ T cell (TCD8) responses is unknown. Moreover, whether recall resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eaecce5f94c5d4c36a1c710cd5ef02c
https://doi.org/10.1371/journal.ppat.1008393
https://doi.org/10.1371/journal.ppat.1008393
Autor:
Hong-Hua Mu, Jimmy D. Dikeakos, Courtney E. Meilleur, Christine M Wardell, S. M. Mansour Haeryfar, Jack R. Bennink, John K. McCormick, Tina Mele
Publikováno v:
The Journal of infectious diseases. 219(8)
Superantigens (SAgs) released by common Gram-positive bacterial pathogens have been reported to delete, anergize, or activate mouse T cells. However, little is known about their effects on preexisting memory CD8(+) T cell (TCD8()) pools. Furthermore,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4caf39b9f55f5452ffeaf0e94a8abc33
https://pubmed.ncbi.nlm.nih.gov/30418594
https://pubmed.ncbi.nlm.nih.gov/30418594
Autor:
Arash Memarnejadian, Courtney E. Meilleur, Delfina M. Mazzuca, Ian Welch, S. M. Mansour Haeryfar
Publikováno v:
Transplantation. 100(5)
Background Preexisting, donor-specific antibodies (DSAs) are culprits of hyperacute rejection. Donor-specific antibodies are also formed de novo, and their role in acute and chronic rejection is increasingly appreciated. However, it is difficult to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3d30e6e18ad96490d3966ba6e18dda
https://pubmed.ncbi.nlm.nih.gov/26985743
https://pubmed.ncbi.nlm.nih.gov/26985743
Autor:
Ram Venkatesh Anantha, S.M.M. Haeryfar, Courtney E. Meilleur, R. Shaler, Jeremy Parfitt, Roberto Hernandez-Alejandro
Publikováno v:
HPB. 18:e135-e136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bb6c6666aff9f57be2d073e810e8c32
https://doi.org/10.1016/j.hpb.2016.02.320
https://doi.org/10.1016/j.hpb.2016.02.320
Autor:
Bhagirath Singh, Peter A. Szabo, Courtney E. Meilleur, Nitan Garg, Maryam Atef Yekta, Mateusz Rytelewski, Shayan Sharif, Anthony M. Jevnikar, S. M. Mansour Haeryfar, Todd D. Schell
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e90439 (2014)
PLoS ONE
PLoS ONE
Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-degrading enzyme known to suppress antitumor CD8(+) T cells (TCD8). The role of IDO in regulation of antiviral TCD8 responses is far less clear. In addition, whether IDO controls both immunodominant a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939f843072261bf3bde4960f9372c9c2
http://europepmc.org/articles/PMC3938761?pdf=render
http://europepmc.org/articles/PMC3938761?pdf=render